Search Results - "RESHEDKO, Galina"
-
1
Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial
Published in The lancet respiratory medicine (01-01-2019)“…Benralizumab is an interleukin-5 receptor α-directed cytolytic monoclonal antibody that has been shown to safely reduce exacerbations and improve lung function…”
Get full text
Journal Article -
2
Antimicrobial resistance of Streptococcus pneumoniae isolated from healthy children in day-care centers: results of a multicenter study in Russia
Published in The Pediatric infectious disease journal (01-03-2000)“…BACKGROUND.It has been previously shown that study of susceptibility of nasopharyngeal isolates in healthy carriers can predict resistance in clinical…”
Get full text
Journal Article -
3
A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae
Published in Journal of antimicrobial chemotherapy (01-09-2008)“…Objectives To evaluate the efficacy and safety of tigecycline in patients with selected serious infections caused by resistant Gram-negative bacteria, or…”
Get full text
Journal Article -
4
Antimicrobial susceptibility of nasopharyngeal isolates of Haemophilus influenzae from healthy children in day-care centres: results of multicentre study in Russia
Published in International journal of antimicrobial agents (01-01-2001)“…Resistance of Haemophilus influenzae from clinical isolates can be predicted on the basis of results of antimicrobial susceptibility of nasopharyngeal…”
Get full text
Journal Article -
5
A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae: Tigecycline, a therapeutic option from a new antimicrobial class (the glycylcyclines) in an era of increasing resistance
Published in Journal of antimicrobial chemotherapy (2008)Get full text
Journal Article